These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6968922)

  • 1. [Evaluation of cellular immunity in melanoma by means of a modified leukocyte migration inhibition test].
    Bowszyc J; Bowszyc J; Wojnerowicz-Grajewska M; Milanowski L
    Przegl Dermatol; 1980; 67(3):319-23. PubMed ID: 6968922
    [No Abstract]   [Full Text] [Related]  

  • 2. The cell-mediated immunity in patients with malignant melanoma.
    Fixa B; Komárková O; Kraus Z; Simková H
    Neoplasma; 1978; 25(3):353-7. PubMed ID: 683378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunology of melanoma].
    Vanwijck R; Bernheim JL; Lejeune FJ
    Acta Chir Belg; 1974 Mar; 73(2):135-88. PubMed ID: 4615541
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor-directed cellular immunity in malignant melanoma and its modification by surgical treatment.
    Cochran AJ; Thomas CE; Spilg WG; Grant RM; Cameron-Mowat DE; Mackie RM; Lindop G
    Yale J Biol Med; 1973 Dec; 46(5):650-4. PubMed ID: 4779137
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunologic mechanisms in malignant melanoma of the skin.
    Cochran AJ
    Trans Ophthalmol Soc U K (1962); 1977 Sep; 97(3):385-8. PubMed ID: 347641
    [No Abstract]   [Full Text] [Related]  

  • 6. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
    Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunologic response in patients with melanoma of the skin].
    Mutsenietse AIa; Volrat AA; Popena BA; Bumbieris IaV; Shapovalova EA
    Vopr Onkol; 1983; 29(4):34-8. PubMed ID: 6858048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immunity to breast carcinoma and malignant melanoma.
    Cochran AJ; Mackie RM; Thomas CE; Grant RM; Cameron-Mowat DE; Spilg WG
    Br J Cancer Suppl; 1973 Aug; 1():77-82. PubMed ID: 4804293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated immunity against malignant melanoma in monozygous twins.
    Nagel GA; St Arneault G; Holland JF; Kirkpatrick D; Kirkpatrick R
    Cancer Res; 1970 Jun; 30(6):1828-32. PubMed ID: 5466283
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cutaneous, cellular immunity in malignant melanoma].
    Kehrer HC
    Wien Klin Wochenschr; 1991; 103(13):396-7. PubMed ID: 1897233
    [No Abstract]   [Full Text] [Related]  

  • 11. Significant reduction of T-cell chemotaxis to MCP-1 in patients with primary and metastatic melanoma.
    Zheng M; Sun G; Cai S; Mueller R; Mrowietz U
    Chin Med J (Engl); 1999 Jun; 112(6):493-6. PubMed ID: 11601324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of surface antigens of transplantable melanomas in hamster on the basis of the macrophage migration inhibition test.
    Kozłowska K; Zurawska-Czupa B; Kostulak A
    Arch Immunol Ther Exp (Warsz); 1981; 29(1):137-42. PubMed ID: 7283676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of cellular immunity in post-traumatic iridocyclitis by means of the leukocyte migration inhibition test].
    Arkhipova LT; Zaitseva NS; Iluridze SL; Gundorova RA
    Oftalmol Zh; 1978; 33(8):565-6. PubMed ID: 570262
    [No Abstract]   [Full Text] [Related]  

  • 14. Cellular reaction to concanavalin A studied by the skin window method in healthy subjects and in patients with malignant tumors.
    Kolár Z; Jansa P; Kovarík J; Skovránková H; Krcová I
    Acta Univ Palacki Olomuc Fac Med; 1987; 117():73-80. PubMed ID: 2977713
    [No Abstract]   [Full Text] [Related]  

  • 15. [Modification of a micromethod for determining leukocyte migration inhibition and its significance in oncological patients].
    Kochetkova VA
    Lab Delo; 1980; (12):744-6. PubMed ID: 6163894
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunological conditions in patients with malignant melanoma of the skin].
    Kristensen E
    Ugeskr Laeger; 1976 Feb; 138(8):463-8. PubMed ID: 1258214
    [No Abstract]   [Full Text] [Related]  

  • 17. [Standardized recall antigen testing in patients with malignant melanoma, endogenous eczema patients and healthy humans].
    Stenger D; Delbrück H; Krumrey K; Zaun H
    Z Hautkr; 1983 Mar; 58(5):293-304. PubMed ID: 6845797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of cellular hypersensitivity of delayed type in patients with rheumatism by the method of leukocyte migration inhibition].
    Borisova AM
    Vopr Revm; 1974; (4):3-9. PubMed ID: 4548604
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunological status of patients with solid neoplasms].
    Citterio F; Luciani G; Pozzetto U; Castagneto M
    Minerva Chir; 1980 May; 35(10):717-22. PubMed ID: 6969868
    [No Abstract]   [Full Text] [Related]  

  • 20. [T-cell immunity in syphilis patients].
    Manuĭlova LA; Fedotov VP; Logunov VP
    Vestn Dermatol Venerol; 1983 Mar; (3):23-7. PubMed ID: 6602434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.